Why Refer for TMS? - Active Path Mental Health in OR and WA

If mental health wasn’t an obstacle, what kind of dreams and goals could your patients be achieving?

Transcranial magnetic stimulation (TMS) is an FDA-cleared, evidence-based treatment for depression and OCD. When your patients are unable to find relief with other treatment methods, TMS is an alternative solution that can offer hope.

In addition to TMS therapy, we offer psychotherapy, a service that fits our capabilities and mission to provide patient-centered, evidence-based collaborative mental healthcare for all. Each session focuses on a specific problem in an effort to guide patients toward results in a shorter timeframe than traditional talk therapy.

Why Refer to Active path mental health?

  • Experienced Experts Using Evidence-Based Techniques
  • Collaborative Approach With Open Communication
    • We collaborate with you as part of your patient’s treatment team and will provide an update at the end of their treatment course.
  • Patient-Focused Care
    • From our initial free consultation to our clinic’s recovery-focused atmosphere, and all the way to the final treatment, our team is dedicated to facilitating each patient’s recovery from depression or OCD.
  • Locally-Based
    • With multiple locations in Oregon and Washington (Clackamas, Hillsboro, Portland, Salem, Tigard and Vancouver) – where your patients live and work.
“The joyous part of what we do is watching lives transform – right before our eyes – in weeks.”
Dr. Pritham Raj, Chief Medical Officer

 Now offering Spravato (esketamine)

  • Introducing the first nasal spray indicated for treatment-resistant depression
      • Spravato (esketamine) is the first prescription nasal spray for adults with treatment resistant depression or symptoms of major depressive disorder (MDD), taken alongside an oral antidepressant.
      • “Spravato works differently than other medications for treatment resistant depression. Unlike most oral antidepressants that treat depression by increasing levels of neurotransmitters such as serotonin, norepinephrine, or dopamine, esketamine targets the NDMA rceptor. NDMA receptors balace the effects of other neurotransmitters and as a result, help the brain to overcome depression.”

    – Y Pritham Raj, MD, FACP – Chief Medical Officer of Active Path Mental Health

    Provider Webinars

    Learn more about Active Path treatment options at one of our upcoming webinars.

    Friday, May 31 l 12:00-1:00 pm

    Alternatives When Traditional Antidepressants Fail

    CE Opportunity Available!

    Join us to discover insights into cutting-edge mental health treatments for depression.

    In this presentation, we will delve into the challenges associated with major depressive disorder (MDD). We will review the history of antidepressant therapy and then learn the intricacies of two newer treatment options, Transcranial Magnetic Stimulation (TMS) and esketamine (Spravato), for treatment-resistant depression.

    The session will cover the efficacy, potential side effects, and the optimal patient candidates for both treatment modalities. We will explore the recommended courses of TMS and Spravato, drawing on case studies, supporting evidence (fair and balanced), and the mechanisms of action.

    Don’t miss out – register now to secure your spot.

    Speaker: Y. Pritham Raj, MD, FACP – Chief Medical Officer, Active Path Mental Health

    woman looking at laptop

    Learn More About TMS

    TMS Treatment Defined

    How TMS Works

    What TMS Treats

    TMS Reviews and Results

    Meet The Team

    Insurance Info

    Patient Journey

    For Anne, and so many like her suffering from major depressive disorders, a feeling of drowning and isolation is all too common. Luckily, in the ocean of treatment-resistant depression, there IS a life-raft: transcranial magnetic stimulation.

    If mental health wasn’t an obstacle, what kind of dreams and goals could your patients be achieving?

    man smiling at camera

    For Your Patient

    Need a brochure for your patient?